Regulatory updates for brain-computer interfaces, 2025–2026
Regulatory updates for brain-computer interfaces, 2025–2026
This source set helps policy analysts track direct BCI and neurotechnology oversight actions, alongside one clearly labeled broader framework that may apply indirectly. It prioritizes official legislation, intergovernmental guidance, regulator material, and a legal analysis documenting recent Chinese measures.
Direct neurotechnology and BCI oversight
Official and intergovernmental materials addressing neurotechnology ethics, BCI clinical development, or neural-data governance. The UNESCO item is adopted guidance, the FDA item is regulator guidance, and the U.S. bill is proposed legislation rather than enacted law.
China: approvals, standards, and consultation
A 2026 legal analysis documenting Chinese BCI actions, including a commercial device approval, an in-force clinical research framework, an industry policy, a technical terminology standard, and draft classification guidance under public consultation. These are reported by a law firm rather than presented as primary government documents.
Broader framework with indirect BCI relevance
An official European Commission consultation on classifying high-risk AI systems. It is not BCI-specific, but may be relevant where BCI software or neurotechnology incorporates regulated high-risk AI functions; treat it as an indirect framework and verify applicability to the device or use case.
Créez votre compte pour conserver cette réponse et la reprendre plus tard.
Examinons les alternatives :
- Modifier la requête.
- Démarrer une nouvelle conversation.
- Supprimer des sources (si elles ont été ajoutées manuellement).
